AUPH logo

AUPH
Aurinia Pharmaceuticals Inc

46,478
Mkt Cap
$2.12B
Volume
1.4M
52W High
$16.29
52W Low
$6.55
PE Ratio
29.01
AUPH Fundamentals
Price
$16.28
Prev Close
$16.11
Open
$16.13
50D MA
$13.03
Beta
0.97
Avg. Volume
1.26M
EPS (Annual)
$0.0393
P/B
5.87
Rev/Employee
$1.81M
Loading...
Loading...
News
all
press releases
Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month High - Here's Why
Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 52-Week High - Time to Buy...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year?
Here is how Aurinia Pharmaceuticals (AUPH) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Zacks·1d ago
News Placeholder
Equities Analysts Offer Predictions for AUPH FY2026 Earnings
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) - Research analysts at Cantor Fitzgerald boosted their FY2026 earnings per share estimates for shares of Aurinia Pharmaceuticals in a...
MarketBeat·17d ago
News Placeholder
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 7.6% Following Analyst Upgrade
Aurinia Pharmaceuticals (NASDAQ:AUPH) Trading 7.6% Higher After Analyst Upgrade...
MarketBeat·17d ago
News Placeholder
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Given Average Rating of "Hold" by Analysts
Shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Get Free Report) (TSE:AUP) have been given an average recommendation of "Hold" by the five research firms that are covering the firm, MarketBeat...
MarketBeat·17d ago
News Placeholder
HC Wainwright Has Optimistic Outlook of AUPH FY2025 Earnings
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) - Equities researchers at HC Wainwright boosted their FY2025 earnings estimates for shares of Aurinia Pharmaceuticals in a note...
MarketBeat·17d ago
News Placeholder
Equities Analysts Set Expectations for AUPH FY2025 Earnings
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) - Equities researchers at Leerink Partnrs increased their FY2025 EPS estimates for shares of Aurinia Pharmaceuticals in a research...
MarketBeat·17d ago
News Placeholder
Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates?
Aurinia Pharmaceuticals (AUPH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks·18d ago
News Placeholder
Q4 EPS Estimate for Aurinia Pharmaceuticals Cut by Analyst
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) - Equities research analysts at HC Wainwright decreased their Q4 2026 earnings estimates for Aurinia Pharmaceuticals in a research...
MarketBeat·18d ago
News Placeholder
Leerink Partnrs Issues Positive Outlook for AUPH Earnings
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) - Analysts at Leerink Partnrs upped their Q1 2026 earnings per share estimates for Aurinia Pharmaceuticals in a note issued to...
MarketBeat·18d ago

Latest AUPH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.